<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2021</volume><submitter>Zhang S</submitter><pubmed_abstract>Chinese herbal Fu-Zheng-Qu-Xie (FZQX) prescription has been found to improve the immune function and survival of patients with early-stage lung cancer. However, the therapeutic efficacy needs to be evaluated objectively, and the precise mechanism remains unclear. In the present study, a double-center, prospective cohort study was carried out to assess the clinical efficacy of the FZQX prescription in preventing the recurrence and metastasis of postoperative early-stage lung adenocarcinoma. Our results indicated that the FZQX prescription could significantly reduce the 3-year postoperative recurrence rate and improve the life quality. Moreover, the peripheral blood indices showed that the positive immune index (CD&lt;sub>4&lt;/sub> &lt;sup>+&lt;/sup>T/CD&lt;sub>8&lt;/sub> &lt;sup>+&lt;/sup>T) increased and the neg</pubmed_abstract><journal>Oxidative medicine and cellular longevity</journal><pagination>6673828</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8133853</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.</pubmed_title><pmcid>PMC8133853</pmcid><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Tian J</pubmed_authors><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Fang Z</pubmed_authors><pubmed_authors>Jiang L</pubmed_authors><pubmed_authors>Xu R</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.</name><description>Chinese herbal Fu-Zheng-Qu-Xie (FZQX) prescription has been found to improve the immune function and survival of patients with early-stage lung cancer. However, the therapeutic efficacy needs to be evaluated objectively, and the precise mechanism remains unclear. In the present study, a double-center, prospective cohort study was carried out to assess the clinical efficacy of the FZQX prescription in preventing the recurrence and metastasis of postoperative early-stage lung adenocarcinoma. Our results indicated that the FZQX prescription could significantly reduce the 3-year postoperative recurrence rate and improve the life quality. Moreover, the peripheral blood indices showed that the positive immune index (CD&lt;sub>4&lt;/sub> &lt;sup>+&lt;/sup>T/CD&lt;sub>8&lt;/sub> &lt;sup>+&lt;/sup>T) increased and the neg</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-18T14:55:25.47Z</modification><creation>2022-02-10T12:57:57.563Z</creation></dates><accession>S-EPMC8133853</accession><cross_references><pubmed>34055197</pubmed><doi>10.1155/2021/6673828</doi></cross_references></HashMap>